CH439290A - Verfahren zur Herstellung von 4-Amino-6,7-dialkoxychinolinen - Google Patents
Verfahren zur Herstellung von 4-Amino-6,7-dialkoxychinolinenInfo
- Publication number
- CH439290A CH439290A CH1498063A CH1498063A CH439290A CH 439290 A CH439290 A CH 439290A CH 1498063 A CH1498063 A CH 1498063A CH 1498063 A CH1498063 A CH 1498063A CH 439290 A CH439290 A CH 439290A
- Authority
- CH
- Switzerland
- Prior art keywords
- dialkoxyquinolines
- amino
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US242646A US3272824A (en) | 1962-12-06 | 1962-12-06 | 4-amino-6, 7-di(lower) alkoxyquinolines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH439290A true CH439290A (de) | 1967-07-15 |
Family
ID=22915626
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH1498063A CH439290A (de) | 1962-12-06 | 1963-12-05 | Verfahren zur Herstellung von 4-Amino-6,7-dialkoxychinolinen |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US3272824A (de) |
| AT (1) | AT248437B (de) |
| BE (1) | BE640817A (de) |
| BR (1) | BR6355254D0 (de) |
| CH (1) | CH439290A (de) |
| DK (1) | DK107024C (de) |
| ES (1) | ES292176A1 (de) |
| FI (1) | FI41554B (de) |
| GB (1) | GB1010254A (de) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1035777A (en) * | 1963-08-20 | 1966-07-13 | Bellon Labor Sa Roger | Isoquinoline derivatives |
| FR6103M (de) * | 1967-02-22 | 1968-06-10 | ||
| US3502681A (en) * | 1968-04-10 | 1970-03-24 | Roussel Uclaf | 7- or 8-chloro-4-phenylamino-chloroquinolines |
| US3668207A (en) * | 1970-01-22 | 1972-06-06 | Ciba Geigy Corp | 2-amino-4-aryl-quinolines |
| US3856796A (en) * | 1972-04-19 | 1974-12-24 | Sandoz Ag | Hydroxyalkyl-substituted-amino-quinolines and nitrates thereof |
| US4035367A (en) * | 1974-09-09 | 1977-07-12 | Sandoz, Inc. | Hydroxyalkyl-substituted-amino-quinolines |
| US4656174A (en) * | 1982-07-24 | 1987-04-07 | Pfizer Inc. | Quinoline therapeutic agents |
| US4771052A (en) * | 1987-02-05 | 1988-09-13 | Hoechst-Roussel Pharmaceuticals, Inc. | Tetrahydropyrido[3',4':4,5]pyrrolo[2,3-c]quinolines and their use as hypotensive agents |
| US5480883A (en) * | 1991-05-10 | 1996-01-02 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase |
| USRE37650E1 (en) | 1991-05-10 | 2002-04-09 | Aventis Pharmacetical Products, Inc. | Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase |
| US5714493A (en) * | 1991-05-10 | 1998-02-03 | Rhone-Poulenc Rorer Pharmaceuticals, Inc. | Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase |
| JPH05213884A (ja) * | 1991-06-14 | 1993-08-24 | Upjohn Co:The | 新規な４−アミノキノリン類およびこれを有効成分とする高血圧・鬱血性心不全の予防・治療剤 |
| NZ331191A (en) | 1996-03-05 | 2000-03-27 | Zeneca Ltd | 4-anilinoquinazoline derivatives and pharmaceutical compositions thereof |
| DE69733825T2 (de) * | 1996-09-25 | 2006-06-08 | Astrazeneca Ab | Chinolin-derivate die den effekt von wachstumsfaktoren wie vegf vezögern |
| US6159978A (en) * | 1997-05-28 | 2000-12-12 | Aventis Pharmaceuticals Product, Inc. | Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases |
| US6245760B1 (en) | 1997-05-28 | 2001-06-12 | Aventis Pharmaceuticals Products, Inc | Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases |
| US6180632B1 (en) | 1997-05-28 | 2001-01-30 | Aventis Pharmaceuticals Products Inc. | Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases |
| AU2002338896B2 (en) | 2001-05-21 | 2006-04-27 | F.Hoffman-La Roche Ag | Quinoline derivatives as ligands for the neuropeptide Y receptor |
| US6787558B2 (en) * | 2001-09-28 | 2004-09-07 | Hoffmann-La Roche Inc. | Quinoline derivatives |
| US20070197538A1 (en) * | 2004-10-07 | 2007-08-23 | Mark Nesbit | Anti-vascular and anti-proliferation methods, therapies, and combinations employing specific tyrosine kinase inhibitors |
| EP3359526A4 (de) | 2015-10-05 | 2019-04-03 | The Trustees of Columbia University in the City of New York | Aktivatoren von autophagischem fluss und phospholipase d und reinigung von proteinaggregaten einschliesslich tau und behandlung von proteinopathien |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2555943A (en) * | 1947-06-28 | 1951-06-05 | Sterling Drug Inc | Dihalo-4-(aliphatic tertiaryamino-alkylamino)quinolines |
| US2940974A (en) * | 1957-06-19 | 1960-06-14 | Sterling Drug Inc | 1-substituted-4-[(tertiary-or secondary-amino)-alkylimino]-1, 4-dihydroquinolines |
| US2940976A (en) * | 1957-06-19 | 1960-06-14 | Sterling Drug Inc | 1-(lower-alkyl)-4-(quaternary-ammonium-alkylimino)-1, 4-dihydroquinolines |
| US3002001A (en) * | 1958-04-03 | 1961-09-26 | Sterling Drug Inc | 4-alkylimino-1-[aromatic-(lower - alkyl)]-1,4-dihydroquinolines and their preparation |
-
1962
- 1962-12-06 US US242646A patent/US3272824A/en not_active Expired - Lifetime
-
1963
- 1963-10-02 GB GB38781/63A patent/GB1010254A/en not_active Expired
- 1963-10-03 ES ES292176A patent/ES292176A1/es not_active Expired
- 1963-11-29 DK DK559363AA patent/DK107024C/da active
- 1963-12-04 FI FI2401/63A patent/FI41554B/fi active
- 1963-12-04 BE BE640817A patent/BE640817A/xx unknown
- 1963-12-05 CH CH1498063A patent/CH439290A/de unknown
- 1963-12-06 AT AT977363A patent/AT248437B/de active
- 1963-12-06 BR BR155254/63A patent/BR6355254D0/pt unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK107024C (da) | 1967-04-17 |
| BE640817A (de) | 1964-04-01 |
| AT248437B (de) | 1966-07-25 |
| GB1010254A (en) | 1965-11-17 |
| ES292176A1 (es) | 1964-02-16 |
| BR6355254D0 (pt) | 1973-07-19 |
| US3272824A (en) | 1966-09-13 |
| FI41554B (de) | 1969-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CH439290A (de) | Verfahren zur Herstellung von 4-Amino-6,7-dialkoxychinolinen | |
| CH453340A (de) | Verfahren zur Herstellung von trans-Dimethylolcyclohexan-1,4 | |
| AT251599B (de) | Verfahren zur Herstellung von neuen 2-Guanidinoalkyl-1,4-benzodioxanen | |
| CH449610A (de) | Verfahren zur Herstellung von Oestra-4,9-dien-3-olen | |
| AT242863B (de) | Verfahren zur Herstellung von α-Amino-arylmethylpenicillinen | |
| CH430704A (de) | Verfahren zur Herstellung von 4,7-Dihalogen-1-methylindan-3-onen | |
| AT238702B (de) | Verfahren zur Herstellung von 1-Acetoxy-1,1-dicyanoäthan | |
| CH460812A (de) | Verfahren zur Herstellung von Acylphenyldichloracetamino-1,3-propandiolen | |
| AT250582B (de) | Verfahren zur Herstellung von 2-Oxa-3-oxo-steroiden | |
| CH439282A (de) | Verfahren zur Herstellung von 11-Keto-5a,9B,10a-19-nor-steroiden | |
| CH416653A (de) | Verfahren zur Herstellung von 2-Methyl-3-o-äthylphenyl-4-oxo-3,4-dihydro-chinazolin | |
| CH442306A (de) | Verfahren zur Herstellung von 3,4-Dihydro-benzoxazinonen-(1,3,2) | |
| CH475985A (de) | Verfahren zur Herstellung von substituierten 2-Oxo-tetrahydrochinolinen | |
| AT241433B (de) | Verfahren zur Herstellung von N-Trifluormethyl-N-aryl-aminosulfensäurehalogeniden | |
| CH464184A (de) | Verfahren zur Herstellung von 6B,19B-Oxido-3,5-cyclosteroiden | |
| AT231451B (de) | Verfahren zur Herstellung von 2, 6-Diketo-8-thiapurinen | |
| CH428769A (de) | Verfahren zur Herstellung von 1,8-Dihydroxyanthrachinonyl-5-thioäthern | |
| CH431507A (de) | Verfahren zur Herstellung von 1,2,3,4-Tetrachlor-9-anthron | |
| CH433355A (de) | Verfahren zur Herstellung von 2,4-Diamino-6-hydroxymethyl-7,8-dihydro-pteridin | |
| CH421122A (de) | Verfahren zur Herstellung von 1,3,4-Oxdiazolen | |
| CH435260A (de) | Verfahren zur Herstellung von 19-Hydroxy-4,5-dehydro-3-oxo-steroiden | |
| CH441369A (de) | Verfahren zur Herstellung von (4-Phenoxy-3,5-dijod-phenyl)-alkanolen | |
| AT242149B (de) | Verfahren zur Herstellung von 2-Sulfanilamido-5-methoxypyrimidin | |
| AT257064B (de) | Verfahren zur Herstellung von 16α-Hydroxysteroiden | |
| CH409978A (de) | Verfahren zur Herstellung von 1-Aryl-hydropyrazolen |